Biocon

In News

Biocon (NSEI:BIOCON) Stock Gets Fair Value Bump As Analysts Weigh Execution And Earnings Visibility - Yahoo Finance

Yahoo Finance - Sep 20, 2026

Biocon's CHRO On Why AI Fluency Is The New Career Currency - BW People

BW People - Sep 20, 2026

Roche sues Biocon over proposed breast-cancer drug copy - Reuters

Reuters - Jul 30, 2026

Biocon inks 10-year supply contract for breast cancer drug in Brazil - pharma.economictimes.indiatimes.com

pharma.economictimes.indiatimes.com - Sep 08, 2026

Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili - Business Wire

Business Wire - Jul 09, 2026

Watch India's Biocon on Generic GLP-1 Push - bloomberg.com

bloomberg.com - May 11, 2026

Shreehas P Tambe - Chief Executive Officer and Managing Director - biocon.com

biocon.com - Apr 04, 2026

#Advertisement feature presented by Biocon | Developing more accessible treatments - BBC

BBC - Jun 25, 2026

Russia strikes Ukraine's largest pharmaceutical warehouse: losses could reach billions - Українська правда

Українська правда - Sep 03, 2026

Mylan to sell up to $363 million stake in India's Biocon, term sheet shows - Reuters

Reuters - Jul 13, 2026

Biocon Receives Health Canada Approval of Bosaya™ (Denosumab) and Vevzuo™ (Denosumab), Biosimilars to Prolia - Business Wire

Business Wire - Apr 21, 2026

Watch Biocon's Mazumdar-Shaw Says Firm On Track To Be Top Insulin Maker - bloomberg.com

bloomberg.com - Jun 16, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment